Biodesix (BDSX) Free Cash Flow (2019 - 2026)

Biodesix has reported Free Cash Flow for 8 years, with the latest figure at -$10.2 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 18.13% year-over-year to -$10.2 million; the trailing twelve-month figure through Mar 2026 stood at -$25.1 million (up 44.23% YoY), and the FY2025 full-year result was -$23.5 million, up 54.64% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$10.2 million, down from $692000.0 in the prior quarter.
• The five-year high for Free Cash Flow was $692000.0 in Q4 2025, with the low at -$20.5 million in Q2 2024.
• Historically, Free Cash Flow has averaged -$10.6 million across 5 years, with a median of -$10.2 million in 2026.
• Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 1326.58% — and 2025, when it surged 114.02%.
• Biodesix's Free Cash Flow stood at -$13.9 million in 2022, then dropped by 10.01% to -$15.3 million in 2023, then surged by 67.68% to -$4.9 million in 2024, then surged by 114.02% to $692000.0 in 2025, then slumped by 1581.07% to -$10.2 million in 2026.
• The last three Free Cash Flow figures came in at -$10.2 million (Q1 2026), $692000.0 (Q4 2025), and -$8.9 million (Q3 2025), per Business Quant data.